Publications

Hanna J, Langdon CG, Garcia MR, Benton A, Lanman NA, Finkelstein D, Rehg JE, Hatley ME. Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2‐Cre mice. The Journal of Pathology 257, 109-124 (2022). 

Hanna J, Garcia M, Lardennois A, Leavey P, Maglic D, Fagnan A, Go J, Roach J, Wang Y, Finkelstein D, Hatley M. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Oncogene 37, 1991–2007 (2018).

Drummond C*, Hanna J*, Garcia M, Devine D, Heyrana A, Finkelstein D, Rehg J, Hatley M. Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from non-myogenic endothelial progenitors. Cancer Cell 33, 108-124 (2018). [*co-first authors].

Hanna J, Drummond C, Garcia M, Go J, Finkelstein D, Rehg J, Hatley M. Biallelic Dicer1 loss mediated by aP2-Cre drives angiosarcoma. Cancer Research 77, 6109-6118, (2017).

Hanna J, Garcia M, Go J, Finkelstein D, Kodali K, Pagala X, Peng J, Hatley M. PAX7 is a required target for microRNA-206 induced differentiation of fusion-negative rhabdomyosarcoma. Cell Death and Disease 7, e2256 (2016).

Agarwal S, Hanna J, Sherman J, Figueroa, Rimm D. Quantitative Assessment of miR-34a as an Independent Prognostic Marker in Breast Cancer. British Journal of Cancer 112, 61–68 (2015).

Hanna J, Hahn, L, Agarwal S, Rimm D. In situ Measurement of miR-205 in Malignant Melanoma Tissue Supports its Role as a Tumor Suppressor microRNA. Laboratory Investigation 92, 1390-1397 (2012).

Genovese G, Ergun A, Shukla S, Campos B, Hanna J, Ghosh P, Quayle S, Rai D, Colla K, Ying H, Wu C, Sarkar S, Xiao Y, Zhang J, Zhang H, Kwong L, Dunn K, Wiedemeyer W, Brennan C, Zheng H, Rimm D, Collins J, Chin L. MicroRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF beta Signaling in GBM. Cancer Discovery 2, 736-749 (2012).

Hanna J, Wimberly H, Kumar S, Slack F, Agarwal S, Rimm D. Quantitative Analysis of microRNAs in Tissue Microarrays by in situ Hybridization. Biotechniques 52, 235-245 (2012).

Baquero M, Hanna J, Neumeister V, Cheng H, Molinaro A, Harris L, Rimm D. Stathmin Expression and its Relationship to Microtubule Associated Protein Tau and Outcome in Breast Cancer. Cancer 118, 4660-4669 (2012).

Scott K, Nogueira C, Heffernan T, van Doorn R, Dhakal S, Hanna J, Min C, Jaskelioff M, Xiao Y, Wu C, Cameron L, Perry S, Zeid R, Feinberg T, Kim M, Vande Woude G, Granter S, Bosenberg M, Chu G, DePinho R, Rimm D, Chin L. Proinvasion Metastasis Drivers in Early-Stage Melanoma are Oncogenes. Cancer Cell 20, 92-103 (2011).

Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, Anagnostou V, Rimm D. Antibody Validation. Biotechniques 48, 197-209 (2010).

Hanna J, Bordeaux J, Rimm D, Agarwal S. The Function, Proteolytic Processing, and Histopathology of Met in Cancer. Adv. Cancer Res.103:1-23 (2009).